Skip to main content
. 2006 Aug 23;62(1):36–42. doi: 10.1136/thx.2006.059410

graphic file with name tx59410.f2.jpg

Figure 2 (A) Bronchoalveolar lavage neutrophil count, (B) myeloperoxidase, (C) tumour necrosis factor α (TNFα) and (D) interleukin (IL)8 in normals, patients at risk from acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) and patients with ALI/ARDS at baseline and after 4 days of treatment with intravenous salbutamol (salb).